European Respiratory Review, 2022 Background Respiratory syncytial virus (RSV) significantly impacts the health of older and high-risk adults (those with comorbidities). We aimed to synthesise the evidence on RSV disease burden and RSV-related healthcare utilisation in both populations ...
J. Nguyen-Van-Tam +8 more
semanticscholar +1 more source
Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-2018
JAMA Network Open, 2022 Key Points Question What was the excess mortality from respiratory syncytial virus (RSV) and influenza in the US from 1999 to 2018? Findings This cross-sectional study estimates a mean of 6549 underlying respiratory deaths associated with RSV each year ...
C. Hansen +3 more
semanticscholar +1 more source
Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein [PDF]
, 2014 Infections with human respiratory syncytial virus (HRSV) occur globally in all age groups and can have devastating consequences in young infants. We demonstrate that a vaccine based on the extracellular domain (SHe) of the small hydrophobic (SH) protein ...
Bert Schepens +20 more
core +11 more sources
Study of the Mechanism of Antiviral Activity of Cytovir®-3 Against Respiratory Viruses In Vitro
Антибиотики и Химиотерапия, 2023 Introduction. The requirements of modern clinical guidelines for the treatment of respiratory viral infections suggest the possibility of identifying a specific viral pathogen.
V. V. Zarubaev +6 more
doaj +1 more source
The incidence and clinical burden of respiratory syncytial virus disease identified through hospital outpatient presentations in Kenyan children [PDF]
, 2012 There is little information that describe the burden of respiratory syncytial virus (RSV) associated disease in the tropical African outpatient setting. Methods We studied a systematic sample of children aged
Ann Bett +35 more
core +5 more sources
Human Vaccines & Immunotherapeutics, 2021 To date, there is no consensus regarding palivizumab prophylaxis for respiratory syncytial virus infection. The purpose of this study is to assess the effectiveness of palivizumab prophylaxis to prevent respiratory syncytial virus-related infection ...
Natividad Viguria +5 more
doaj +1 more source
Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan
Emerging Infectious Diseases, 2021 More than a year into the coronavirus-19 pandemic, intensified infection control measures have controlled most viral respiratory infections in Tokyo, Japan. As of July 2021, however, an unusually high number of respiratory syncytial virus infections were
M. Ujiie +3 more
semanticscholar +1 more source
Respiratory Syncytial Virus Vaccines [PDF]
Clinical Microbiology Reviews, 1998 SUMMARYRespiratory syncytial virus (RSV) is the most important cause of viral lower respiratory tract illness (LRI) in infants and children worldwide and causes significant LRI in the elderly and in immunocompromised patients. The goal of RSV vaccination is to prevent serious RSV-associated LRI.
R A, Dudas, R A, Karron
openaire +5 more sources
RSV infection and recurrence of respiratory tract obstruction in children
Pediatria i Medycyna Rodzinna, 2016 Viruses, including the respiratory syncytial virus, are the most common aetiological factor of respiratory infections in children. The disease most often occurs between November and April in the northern climate zone, with a peak incidence in January ...
Karolina Kapusta +2 more
doaj +1 more source
Incidence of viral respiratory infections in a prospective cohort of outpatient and hospitalized children aged ≤5 years and its associated cost in Buenos Aires, Argentina [PDF]
, 2015 Background: Although information about the incidence of viral respiratory illnesses and their associated cost can help health officials explore the value of interventions, data are limited from middle-income countries.
Azziz Baumgartner, Eduardo +6 more
core +1 more source